FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

STERN ADAM K		 2. Issuer Name and Ticker or Trading Symbol

DarioHealth Corp. [ DRIO ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

8 HATOKHEN STREET		 3. Date of Earliest Transaction (MM/DD/YYYY)

7/8/2020
(Street)

CAESAREA INDUSTRIAL PARK, L3 3088900
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
 6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock         19049 D  
Common Stock         2500 I AKS Family Foundation, Inc. 
Common Stock         15500 I AKS Family Partners 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		8. Price of Derivative Security
(Instr. 5)		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock Warrant $4.05 7/8/2020  D     253911 (1) 12/19/2019 12/19/2024 Common Stock 253911 $0 (1)0 D  
Common Stock Warrant $4.05 7/8/2020  A   231383 (1)   12/19/2019 12/19/2024 Common Stock 231383 $0 (1)231383 D  
Common Stock Warrant $4.28 7/8/2020  D     25676 (2) 12/19/2019 12/19/2024 Common Stock 25676 $0 (2)0 D  
Common Stock Warrant $4.28 7/8/2020  A   22108 (2)   12/19/2019 12/19/2024 Common Stock 22108 $0 (2)22108 D  
Common Stock Warrant $4.98 7/8/2020  D     10086 (3) 12/19/2019 12/19/2024 Common Stock 10086 $0 (3)0 D  
Common Stock Warrant $4.98 7/8/2020  A   36900 (3)   12/19/2019 12/19/2024 Common Stock 36900 $0 (3)36900 D  
Common Stock Warrant $5.90 7/8/2020  D     1525 (4) 12/19/2019 12/19/2024 Common Stock 1525 $0 (4)0 D  
Common Stock Warrant $5.90 7/8/2020  A   807 (4)   12/19/2019 12/19/2024 Common Stock 807 $0 (4)807 D  
Common Stock Warrant $4.05 7/8/2020  A   1593 (5)   12/19/2019 12/19/2024 Common Stock 1593 $0 (5)1593 D  
Common Stock Warrant $4.28 7/8/2020  A   2633 (5)   12/19/2019 12/19/2024 Common Stock 2633 $0 (5)2633 D  
Common Stock Warrant $4.98 7/8/2020  A   1244 (5)   12/19/2019 12/19/2024 Common Stock 1244 $0 (5)1244 D  
Explanation of Responses:
(1) The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of such warrant with Michael Siek, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019.
(2) The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019.
(3) The two reported transactions involved an amendment of an outstanding pursuant to a transfer of a portion of the Warrant with Michael Siek common stock warrant, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019.
(4) The two reported transactions involved an amendment of an outstanding common stock warrant pursuant to a transfer of a portion of the Warrant with Michael Siek, resulting in the deemed cancellation of the "old" warrant and the issuance of a replacement warrant. The warrant was originally issued on December 19, 2019.
(5) The reported transactions involved a transfer of an outstanding common stock warrant from Michael Siek to the reporting person.
Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
STERN ADAM K
8 HATOKHEN STREET
CAESAREA INDUSTRIAL PARK, L3 3088900		X
Signatures
/s/ Adam Stern7/10/2020
**Signature of Reporting PersonDate
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Aug 2024 to Sep 2024 Click Here for more DarioHealth Charts.
DarioHealth (NASDAQ:DRIO)
Historical Stock Chart
From Sep 2023 to Sep 2024 Click Here for more DarioHealth Charts.